Wolverine Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Hold
0
2592
2024
Q4
Hold
0
2563
2024
Q3
Hold
0
2411
2024
Q2
Sell
-13,931
Closed -$68.5K 2339
2024
Q1
$68.5K Buy
+13,931
New +$68.5K ﹤0.01% 1081
2023
Q4
Hold
0
2332
2023
Q3
Sell
-19,346
Closed -$478K 2296
2023
Q2
$478K Sell
19,346
-2,887
-13% -$71.3K ﹤0.01% 546
2023
Q1
$692K Buy
22,233
+8,386
+61% +$261K ﹤0.01% 404
2022
Q4
$256K Buy
13,847
+3,556
+35% +$65.7K ﹤0.01% 664
2022
Q3
$264K Buy
+10,291
New +$264K ﹤0.01% 787
2022
Q2
Hold
0
2534
2022
Q1
Hold
0
2765
2021
Q4
Hold
0
2857
2021
Q3
Hold
0
2842
2021
Q2
Hold
0
2751
2021
Q1
Hold
0
2617
2020
Q4
Hold
0
2283
2020
Q3
Hold
0
2145
2020
Q2
Hold
0
2167
2020
Q1
Hold
0
2169
2019
Q4
Sell
-13,996
Closed -$193K 2106
2019
Q3
$193K Sell
13,996
-5,268
-27% -$72.6K ﹤0.01% 1056
2019
Q2
$250K Buy
+19,264
New +$250K ﹤0.01% 871
2019
Q1
Sell
-17,642
Closed -$342K 2168
2018
Q4
$342K Buy
17,642
+3,499
+25% +$67.8K ﹤0.01% 800
2018
Q3
$351K Buy
+14,143
New +$351K ﹤0.01% 976
2018
Q2
Hold
0
2000
2018
Q1
Sell
-14,237
Closed -$509K 2298
2017
Q4
$509K Buy
+14,237
New +$509K ﹤0.01% 885
2017
Q3
Hold
0
2060
2017
Q2
Hold
0
2045
2017
Q1
Hold
0
2109
2016
Q4
Hold
0
2176